BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 34562070)

  • 1. Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy.
    Tuteja S; Salloum RG; Elchynski AL; Smith DM; Rowe E; Blake KV; Limdi NA; Aquilante CL; Bates J; Beitelshees AL; Cipriani A; Duong BQ; Empey PE; Formea CM; Hicks JK; Mroz P; Oslin D; Pasternak AL; Petry N; Ramsey LB; Schlichte A; Swain SM; Ward KM; Wiisanen K; Skaar TC; Van Driest SL; Cavallari LH; Bishop JR;
    Clin Transl Sci; 2022 Feb; 15(2):371-383. PubMed ID: 34562070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Best-worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy.
    Salloum RG; Bishop JR; Elchynski AL; Smith DM; Rowe E; Blake KV; Limdi NA; Aquilante CL; Bates J; Beitelshees AL; Cipriani A; Duong BQ; Empey PE; Formea CM; Hicks JK; Mroz P; Oslin D; Pasternak AL; Petry N; Ramsey LB; Schlichte A; Swain SM; Ward KM; Wiisanen K; Skaar TC; Van Driest SL; Cavallari LH; Tuteja S
    Implement Sci Commun; 2022 May; 3(1):52. PubMed ID: 35568931
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Forbes M; Hopwood M; Bousman CA
    Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective Review of Pharmacogenetic Testing at an Academic Children's Hospital.
    Roberts TA; Wagner JA; Sandritter T; Black BT; Gaedigk A; Stancil SL
    Clin Transl Sci; 2021 Jan; 14(1):412-421. PubMed ID: 33048453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review and Consensus on Pharmacogenomic Testing in Psychiatry.
    Bousman CA; Bengesser SA; Aitchison KJ; Amare AT; Aschauer H; Baune BT; Asl BB; Bishop JR; Burmeister M; Chaumette B; Chen LS; Cordner ZA; Deckert J; Degenhardt F; DeLisi LE; Folkersen L; Kennedy JL; Klein TE; McClay JL; McMahon FJ; Musil R; Saccone NL; Sangkuhl K; Stowe RM; Tan EC; Tiwari AK; Zai CC; Zai G; Zhang J; Gaedigk A; Müller DJ
    Pharmacopsychiatry; 2021 Jan; 54(1):5-17. PubMed ID: 33147643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does obtaining CYP2D6 and CYP2C19 pharmacogenetic testing predict antidepressant response or adverse drug reactions?
    Solomon HV; Cates KW; Li KJ
    Psychiatry Res; 2019 Jan; 271():604-613. PubMed ID: 30554109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary care and mental health providers' perceptions of implementation of pharmacogenetics testing for depression prescribing.
    Vest BM; Wray LO; Brady LA; Thase ME; Beehler GP; Chapman SR; Hull LE; Oslin DW
    BMC Psychiatry; 2020 Oct; 20(1):518. PubMed ID: 33115428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetic testing among patients with depression in a US managed care population.
    Anderson HD; Thant TM; Kao DP; Crooks KR; Mendola ND; Aquilante CL
    Clin Transl Sci; 2022 Jul; 15(7):1644-1653. PubMed ID: 35385214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing Clinical Utility of Pharmacogenetic Testing in the Military Health System.
    Hellwig LD; Turner C; Olsen C; Libbus J; Markos B; Koehlmoos T; Haigney M; De Castro M; Saunders D
    Mil Med; 2024 Jan; 189(1-2):e198-e204. PubMed ID: 37436924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of targeted vs. expanded pharmacogenomic testing: What are we missing?
    Chambal M; Forsthoffer C; Egnaczyk A; Seitz M; Grande K; Ashcraft K; Wick JA; Blaxall BC
    J Am Pharm Assoc (2003); 2023; 63(3):939-945. PubMed ID: 37024375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antidepressants with pharmacogenetic prescribing guidelines in a 10-year depression cohort of adult primary care patients.
    Jessel CD; Mostafa S; Potiriadis M; Everall IP; Gunn JM; Bousman CA
    Pharmacogenet Genomics; 2020 Sep; 30(7):145-152. PubMed ID: 32433340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics.
    Quaranta S; Dupouey J; Colle R; Verstuyft C
    Therapie; 2017 Apr; 72(2):311-318. PubMed ID: 28237405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal pharmacogenomics: A promising addition to complex neonatal care.
    Raymond M; Critchlow E; Rice SM; Wodoslawsky S; Berger SI; Hegde M; Empey PE; Al-Kouatly HB
    Mol Genet Metab; 2022; 137(1-2):140-145. PubMed ID: 36029725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Providers' Use of Pharmacogenetic Testing to Inform Antidepressant Prescribing: Results of Qualitative Interviews.
    Vest BM; Wray LO; Thase ME; Brady LA; Chapman SR; Oslin DW
    Psychiatr Serv; 2023 Dec; 74(12):1270-1276. PubMed ID: 37528698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing.
    Cavallari LH; Van Driest SL; Prows CA; Bishop JR; Limdi NA; Pratt VM; Ramsey LB; Smith DM; Tuteja S; Duong BQ; Hicks JK; Lee JC; Obeng AO; Beitelshees AL; Bell GC; Blake K; Crona DJ; Dressler L; Gregg RA; Hines LJ; Scott SA; Shelton RC; Weitzel KW; Johnson JA; Peterson JF; Empey PE; Skaar TC;
    Genet Med; 2019 Oct; 21(10):2255-2263. PubMed ID: 30894703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes toward pharmacogenetics in patients undergoing
    Lee G; Varughese LA; Conway L; Stojinski C; Ashokkumar S; Monono K; Matthai W; Kolansky DM; Giri J; Tuteja S
    Per Med; 2022 Mar; 19(2):93-101. PubMed ID: 34984913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetic Testing in Depressed Patients and Interdisciplinary Exchange between a Pharmacist and Psychiatrists Results in Reduced Hospitalization Times.
    Bättig VAD; Roll SC; Hahn M
    Pharmacopsychiatry; 2020 Jul; 53(4):185-192. PubMed ID: 32045941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implementation of preemptive pharmacogenomics in psychiatry: Τhe "PREPARE" study.
    Tsermpini EE; Skokou M; Ferentinos P; Georgila E; Gourzis P; Assimakopoulos K; Patrinos GP;
    Psychiatriki; 2020; 31(4):341-351. PubMed ID: 33361064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant Pharmacotherapy.
    Hicks JK; Bishop JR; Gammal RS; Sangkuhl K; Bousman CA; Leeder JS; Llerena A; Mueller DJ; Ramsey LB; Scott SA; Skaar TC; Caudle KE; Klein TE; Gaedigk A
    Clin Pharmacol Ther; 2020 Jan; 107(1):50-52. PubMed ID: 31664715
    [No Abstract]   [Full Text] [Related]  

  • 20. Opportunities for Pharmacogenetic Testing to Guide Dosing of Medications in Youths With Medicaid.
    Tang Girdwood S; Hall M; Antoon JW; Kyler KE; Williams DJ; Shah SS; Orth LE; Goldman J; Feinstein JA; Ramsey LB
    JAMA Netw Open; 2024 Feb; 7(2):e2355707. PubMed ID: 38349656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.